Development of novel malaria transmission blocking vaccine
Project/Area Number |
21406010
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 海外学術 |
Research Field |
Parasitology (including Sanitary zoology)
|
Research Institution | Ehime University |
Principal Investigator |
TORII Motomi 愛媛大学, 大学院・医学系研究科, 教授 (20164072)
|
Co-Investigator(Kenkyū-buntansha) |
MAYUMI Tachibana 愛媛大学, 大学院医学系研究科, 助教 (00301325)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥17,550,000 (Direct Cost: ¥13,500,000、Indirect Cost: ¥4,050,000)
Fiscal Year 2011: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2010: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2009: ¥6,630,000 (Direct Cost: ¥5,100,000、Indirect Cost: ¥1,530,000)
|
Keywords | マラリア / ワクチン / 伝搬阻止 / 原虫 / 組換えタンパク質 |
Research Abstract |
The aim of the malaria transmission-blocking vaccine(TBV) is to block the development of malaria parasites in the mosquito and prevent the following infection to the host. We focused on the Pvs230 as a candidate molecule, and produced recombinant Pvs230 protein using cell-free system. Rabbit antisera against the rPvs230 reacted on the surface of P. vivax gametocytes taken from Thai patients. The antisera reduced the infectivity of P. vivax parasites to Anopheles dirus mosquitoes by membrane feeding assay.
|
Report
(4 results)
Research Products
(13 results)
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Immunization with N-terninal region of a gametocyte protein Pfs230 successfully induce transmissionblocking antibodies against Plasmodium falciparum2009
Author(s)
Mayumi Tachibana, Hideyuki Iriko, Olga Muratova, Guanhong Song, Yimin Wu, Jetsumon Sattabongkot, Satoru Takeo, Hitoshi Otsuki, Motomi Torii, Takafumi Tsuboi
Organizer
American Society of Tropical Medicine and Hygiene 58^<th> Annual meeting
Place of Presentation
Washington, DC, USA
Related Report
-